TLX

TELIX PHARMACEUTICALS

TLX·87961M105·US·ADR·Healthcare - Biotechnology

TLX (TELIX PHARMACEUTICALS) is held by 22 institutional investors as of Q1 2026. Largest holders: FMR LLC ($5.4M), LAZARD ASSET MANAGEMENT LLC ($2.8M), Private Advisor Group, LLC ($1.7M). Net institutional sentiment: Mixed.

22
Holders
Avg rating(7 Elite)
$15.2M
Total Value
65% (28)
Fund Consensus
17 buying - 9 selling
TLXSmart Money Verdict
View all
Held by 22 funds
7 elite
Who's Trading
InsiderBCBehrenbruch ChristianBuy $497KApr 29, 2026
InsiderBCBehrenbruch ChristianBuy $500KApr 28, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
564,757(+357.0%)$5.4M0.0%+38.47%
44
Increased
289,917(+15.7%)$2.8M0.0%+31.21%
30
Increased
174,415(+276.3%)$1.7M0.0%+28.82%
41
New
164,397$1.6M0.0%+59.83%
35
Increased
116,440(+559.6%)$1.1M0.0%+51.53%
41
Decreased
57,348(-22.9%)$513,8380.0%+31.37%
0
Increased
43,446(+18.8%)$415,3400.0%+46.06%
28
New
34,873$333,7330.0%+59.83%
33
Increased
33,253(+83.3%)$318,2310.0%-6.36%
36
Increased
32,300(+1544.6%)$309,1110.0%+48.09%
26
Increased
26,007(+120.0%)$248,8870.0%+52.09%
37
Decreased
16,653(-38.9%)$159,3700.0%+43.74%
0
Increased
12,000(+700.0%)$114,8400.0%+57.62%
35
Increased
10,031(+523.8%)$95,9970.0%+49.77%
24
Decreased
9,823(-8.9%)$93,9980.0%+22.88%
0
Unchanged
1,920$18,3740.0%-29.52%
0
Increased
756(+140.8%)$7,2350.0%+30.71%
18
Increased
352(+300.0%)$3,3700.0%+55.48%
15
Increased
153(+240.0%)$1,4640.0%+31.19%
12
New
65$6220.0%+59.83%
17

Showing 1-20 of 28

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used